1. Predictors of side effects during the buildup phase of venom immunotherapy for Hymenoptera venom allergy: The importance of baseline serum tryptase† 
Franziska Ruëff, MD, Bernhard Przybilla, MD, Maria Beatrice Biló, MD, Ulrich Müller, MD, Fabian Scheipl, MSc, Werner Aberer, MD, Joëlle Birnbaum, MD, Anna Bodzenta-Lukaszyk, MD, Floriano Bonifazi, MD, Christoph Bucher, MD, Paolo Campi, MD, Ulf Darsow, MD, Cornelia Egger, MD, Gabrielle Haeberli, MD, Thomas Hawranek, MD, Iwona Kucharewicz, MD, Helmut Küchenhoff, PhD, Roland Lang, PhD, Oliviero Quercia, MD, Norbert Reider, MD, Maurizio Severino, MD, Michael Sticherling, MD, Gunter Johannes Sturm, MD, Brunello Wüthrich, MD 
Journal of Allergy and Clinical Immunology 
Volume 126, Issue 1, Pages e5 (July 2010)
DOI: /j.jaci
Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2. Fig 1
Linear function and 95% confidence band (dashed lines) for the effect of BTC on the risk to need an emergency intervention during the buildup phase of vespid immunotherapy (final multivariate generalized additive model). Odds ratios are referred to those of the median of tryptase concentration. The odds ratio of the latter has been set at 1.
Journal of Allergy and Clinical Immunology  , e5DOI: ( /j.jaci )
Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions